+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Middle East and Africa Ophthalmology Drugs and Devices Market 2019-2027

  • ID: 4827803
  • Report
  • Region: Middle East, Africa
  • 96 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
Market Outlook

The report on the ophthalmology drugs and devices market in the Middle East and Africa states that the market is anticipated to burgeon with a CAGR of 6.89% throughout the forecast duration from 2019-2027. The UAE, South Africa, Saudi Arabia, Turkey and countries in rest of MEA together constitute the market for ophthalmology drugs and devices in the Middle East and African region. The pharmaceutical industry was hit by a series of brand patent expirations due to numerous branded drugs going off-patent in the past. However, the present scenario is a matter of concern, as several renowned drugs are almost simultaneously joining the list of expired brand patents. The increase in the number of drugs going off-patent is expected to negatively influence the overall demand for ophthalmic drugs. The demand for drugs will increase shortly, owing to the rising prevalence of eye-related disorders and will shift to generic drugs in case of patent-off of the drugs. Such situations are likely to hamper the market growth to a great extent. The delay in drug approval and the number of drugs in the pipeline act as major concerns for the main players of the ophthalmic drugs market. Before launching any drug in the market, the drug has to go through various stages of development, after which, the manufacturer has to apply to the FDA for its approval. The process of the filing for the approval and its launch is time-consuming, which creates major concern for the market players.

Competitive Outlook
The top key players in the market include Bayer, Essilor International S.A., Johnson & Johnson, Inc., Pfizer and Santen Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
1. Middle East and Africa Ophthalmology Drugs and Devices Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Analysis
2.2.1. Bargaining Power of Buyers
2.2.2. Bargaining Power of Supplier
2.2.3. Threats of New Entrants
2.2.4. Threats of Substitutes
2.2.5. Competitive Rivalry
2.3. Strategic Outlook
2.4. Key Insight
2.5. Value Chain Outlook
2.6. Key Buying Standards
2.7. Investment Outlook
2.8. Supply Chain Outlook
2.9. Market Drivers
2.9.1. Increasing Ophthalmic Disorders Due to High Blood Sugar
2.9.2. Upsurge in Healthcare Spending
2.9.3. Technological Advancement
2.10. Market Restraints
2.10.1. Expirations of Brand Patents Have Affected the Pharmaceutical Industry
2.10.2. Low Cognizance Related to Ophthalmic Drugs
2.10.3. Drug Approvals Delay and Number of Drugs in the Pipeline
2.11. Market Opportunities
2.11.1. Demand for Phacoemulsification Devices and Intraocular Lenses Is Increasing
2.12. Market Challenges
2.12.1. Difficulties Associated With the Conduct of Ocular Diseases

3. Ophthalmology Drugs and Devices Market Outlook - by Drugs and Devices
3.1. Devices
3.1.1. Diagnostic & Monitoring Equipment
3.1.1.1. Optical Coherence Tomography
3.1.1.2. Ophthalmic Ultrasound Imaging Systems
3.1.1.3. Fundus Camera Market
3.1.1.4. Ophthalmoscopes
3.1.1.5. Retinoscope
3.1.1.6. Pachymeter
3.1.1.7. Wavefront Aberrometers
3.1.1.8. Perimeters/Visual Field Analyzer
3.1.1.9. Autorefractors/Phoropter
3.1.1.10. Specular Microscope
3.1.1.11. Corneal Topographers
3.1.1.12. Other Diagnostic & Monitoring Equipment Market
3.1.2. Surgery Devices
3.1.2.1. Cataract Surgery Devices
3.1.2.2. Glaucoma Surgery Devices
3.1.2.3. Refractive Surgery Devices
3.1.2.4. Vitreoretinal Surgery Devices
3.1.3. Vision Care
3.2. Drugs
3.2.1. Glaucoma Drug
3.2.2. Retinal Disorder Drug
3.2.3. Dry Eye Drug
3.2.4. Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug
3.2.5. Drugs by Use of Preservation
3.2.5.1. Preserved Drugs
3.2.5.2. Preservative-Free Drugs

4. Ophthalmology Drugs and Devices Market - Regional Outlook
4.1.1. United Arab Emirates
4.1.2. Saudi Arabia
4.1.3. Turkey
4.1.4. South Africa
4.1.5. Rest of Middle East & Africa

5. Competitive Landscape
5.1. Allergan, Inc.
5.2. Bayer
5.3. Carl Zeiss AG
5.4. Essilor International S.A.
5.5. Glaxosmithkline
5.6. Johnson & Johnson, Inc.
5.7. Novartis International AG
5.8. Pfizer
5.9. Roche Holding AG
5.10. Santen Pharmaceutical Co., Ltd.

6. Methodology and Scope
6.1. Research Scope
6.2. Sources of Data
6.3. Research Methodology

List of Tables
Table 1 Middle East and Africa Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Table 2 Common Causes of Loss of Vision in the Elderly
Table 3 Selected Lists of Glaucoma Drugs in Late-Stage Clinical Trials
Table 4 Middle East and Africa Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 5 Middle East and Africa Devices Market in Diagnostic & Monitoring Equipment by Types 2019-2027 ($ Million)
Table 6 Middle East and Africa Devices Market in Surgery Device by Types 2019-2027 ($ Million)
Table 7 Middle East and Africa Drugs and Devices Market in Drugs by Types 2019-2027 ($ Million)
Table 8 Middle East and Africa Ophthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)

List of Figures
Figure 1 Middle East and Africa Ophthalmology Drugs and Devices Market 2019-2027
Figure 2 Middle East and Africa Drugs and Devices Market in Devices 2019-2027 ($ Million)
Figure 3 Middle East and Africa Devices Market in Diagnostic & Monitoring Equipment 2019-2027 ($ Million)
Figure 4 Middle East and Africa Diagnostic & Monitoring Equipment Market in Optical Coherence Tomography 2019-2027 ($ Million)
Figure 5 Middle East and Africa Diagnostic & Monitoring Equipment Market in Ophthalmic Ultrasound Imaging Systems 2019-2027 ($ Million)
Figure 6 Middle East and Africa Diagnostic & Monitoring Equipment Market in Fundus Camera Market 2019-2027 ($ Million)
Figure 7 Middle East and Africa Diagnostic & Monitoring Equipment Market in Ophthalmoscopes 2019-2027 ($ Million)
Figure 8 Middle East and Africa Diagnostic & Monitoring Equipment Market in Retinoscope 2019-2027 ($ Million)
Figure 9 Middle East and Africa Diagnostic & Monitoring Equipment Market in Pachymeter 2019-2027 ($ Million)
Figure 10 Middle East and Africa Diagnostic & Monitoring Equipment Market in Wavefront Aberrometers 2019-2027 ($ Million)
Figure 11 Middle East and Africa Diagnostic & Monitoring Equipment Market in Perimeters/Visual Field Analyzer 2019-2027 ($ Million)
Figure 12 Middle East and Africa Diagnostic & Monitoring Equipment Market in Autorefractors/Phoropter 2019-2027 ($ Million)
Figure 13 Middle East and Africa Diagnostic & Monitoring Equipment Market in Specular Microscope 2019-2027 ($ Million)
Figure 14 Middle East and Africa Diagnostic & Monitoring Equipment Market in Corneal Topographers 2019-2027 ($ Million)
Figure 15 Middle East and Africa Diagnostic & Monitoring Equipment Market in Other Diagnostic & Monitoring Equipment Market 2019-2027 ($ Million)
Figure 16 Middle East and Africa Devices Market in Surgery Device 2019-2027 ($ Million)
Figure 17 Middle East and Africa Surgery Devices Market in Cataract Surgery Devices 2019-2027 ($ Million)
Figure 18 Middle East and Africa Surgery Devices Market in Glaucoma Surgery Devices 2019-2027 ($ Million)
Figure 19 Middle East and Africa Surgery Devices Market in Refractive Surgery Devices 2019-2027 ($ Million)
Figure 20 Middle East and Africa Surgery Devices Market in Vitreoretinal Surgery Devices 2019-2027 ($ Million)
Figure 21 Middle East and Africa Devices Market in Vision Care Market 2019-2027 ($ Million)
Figure 22 Middle East and Africa Drugs and Devices Market in Drugs 2019-2027 ($ Million)
Figure 23 Middle East and Africa Drugs Market in Glaucoma Drug 2019-2027 ($ Million)
Figure 24 Middle East and Africa Drugs Market in Retinal Disorder Drug 2019-2027 ($ Million)
Figure 25 Middle East and Africa Drugs Market in Dry Eye Drug 2019-2027 ($ Million)
Figure 26 Middle East and Africa Drugs Market in Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug 2019-2027 ($ Million)
Figure 27 Middle East and Africa Drugs by Use of Preservation in Preserved Drugs 2019-2027 ($ Million)
Figure 28 Middle East and Africa Drugs by Use of Preservation in Preservative-Free Drugs 2019-2027 ($ Million)
Figure 29 Middle East and Africa Preservative-Free Drugs Market in Single-Dose 2019-2027 ($ Million)
Figure 30 Middle East and Africa Preservative-Free Drugs Market in Multi-Dose 2019-2027 ($ Million)
Figure 31 Saudi Arabia Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 32 Turkey Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 33 United Arab Emirates Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 34 South Africa Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 35 Rest of Middle East & Africa Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Essilor International S.A.
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • Pfizer
  • Roche Holding AG
  • Santen Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll